Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.48 |
| ▸ | TYR | P14679 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 5/20 | 0.45 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.44 |
| ▸ | PLG | P00747 | 2/20 | 0.43 |
| ▸ | KLK1 | P06870 | 2/20 | 0.43 |
| ▸ | KLK6 | Q92876 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13175418 | 0.88 | MAPT (0.61) | MAPTPOLBNPC1RAB9AGAA | |
| SCHEMBL22628682 | 0.85 | NPC1 (0.47) | MAPTPOLBNPC1RAB9AGAA | |
| SCHEMBL25494289 | 0.84 | GAA (0.64) | MAPTPOLBNPC1RAB9ATRPA1 | |
| SCHEMBL12190515 | 0.82 | ALDH1A1 (0.52) | MAPTPOLBNPC1RAB9ATRPA1 | |
| SCHEMBL25509853 | 0.81 | MAPK1 (0.50) | MAPTPOLBNPC1RAB9ATRPA1 | |
| SCHEMBL18503024 | 0.81 | HDAC1 (0.55) | MAPTPOLBNPC1RAB9AGAA | |
| SCHEMBL3983979 | 0.81 | CA1 (0.55) | MAPTPOLBNPC1RAB9AGAA | |
| SCHEMBL10620579 | 0.81 | CA1 (0.54) | MAPTPOLBNPC1RAB9AALDH1A1 | |
| SCHEMBL3987763 | 0.79 | KDM4E (0.61) | MAPTPOLBNPC1RAB9ACYP2C19 | |
| SCHEMBL14197222 | 0.79 | GAA (0.47) | MAPTPOLBNPC1RAB9ATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6752839-B1 | 2-SUBSTITUTED 5-AMINOALKYLPHENOL DERIVATIVE COUPLER AND PYRAZOLES, CERTAIN PYRIMIDINES AND/OR PYRAZOLOPYRIMIDINES BASES; CHROMATIC, STRONG, AESTHETIC COLORATIONS IN VARIETY OF SHADES | L'OREAL (FR) | 2004-06-22 | — | — | US | claimed |
| US-6530960-B1 | Oxidative base at least one 2-substituted 5-aminoalkylphenol coupler; chromatic, strong, aesthetic colorations in a variety of shades | L'OREAL S.A. (FR) | 2003-03-11 | — | — | US | claimed |
| EP-1093788-A1 | Oxydative dyeing composition for keratinic fibres and dyeing process using this composition | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| EP-1093789-A1 | Composition for oxidative dyeing of keratinous fibres and dyeing process using the same | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| EP-1093790-A2 | Oxydative dyeing composition for keratinic fibres and dyeing process using this composition | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| EP-1093792-A1 | Composition for oxidative dyeing of keratinous fibres and dyeing process using the same | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| EP-1093793-A2 | Composition for oxidative dyeing of keratinous fibres and dyeing process using same | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| EP-1093791-A1 | Composition for oxidative dyeing of keratinous fibres and dyeing process using same | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| US-11976061-B2 | Preparation of benzimidazolone derivatives as novel diacylglyceride O-acyltransferase 2 inhibitors | Merck Sharp & Dohme, LLC (US) | 2024-05-07 | — | — | US | disclosed |
| US-11976061-B2 | Preparation of benzimidazolone derivatives as novel diacylglyceride O-acyltransferase 2 inhibitors | Merck Sharp & Dohme, LLC (US) | 2024-05-07 | — | — | US | disclosed |
| US-20210363147-A1 | NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2021-11-25 | — | — | US | disclosed |
| WO-2021236401-A1 | NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2021-11-25 | — | — | WO | disclosed |
| US-6752839-B1 | 2-SUBSTITUTED 5-AMINOALKYLPHENOL DERIVATIVE COUPLER AND PYRAZOLES, CERTAIN PYRIMIDINES AND/OR PYRAZOLOPYRIMIDINES BASES; CHROMATIC, STRONG, AESTHETIC COLORATIONS IN VARIETY OF SHADES | L'OREAL (FR) | 2004-06-22 | — | — | US | disclosed |
| US-6530960-B1 | Oxidative base at least one 2-substituted 5-aminoalkylphenol coupler; chromatic, strong, aesthetic colorations in a variety of shades | L'OREAL S.A. (FR) | 2003-03-11 | — | — | US | disclosed |
| EP-1093788-A1 | Oxydative dyeing composition for keratinic fibres and dyeing process using this composition | L'OREAL (FR) | 2001-04-25 | — | — | EP | disclosed |
| EP-1093789-A1 | Composition for oxidative dyeing of keratinous fibres and dyeing process using the same | L'OREAL (FR) | 2001-04-25 | — | — | EP | disclosed |
| EP-1093792-A1 | Composition for oxidative dyeing of keratinous fibres and dyeing process using the same | L'OREAL (FR) | 2001-04-25 | — | — | EP | disclosed |
| EP-1093790-A2 | Oxydative dyeing composition for keratinic fibres and dyeing process using this composition | L'OREAL (FR) | 2001-04-25 | — | — | EP | disclosed |
| US-5334225-A | Imparts color tone of high chroma; excellent in coloring power and fastness | KAO CORPORATION (JP) | 1994-08-02 | — | — | US | disclosed |
| EP-0579204-A2 | Dye composition for a keratinous fiber | KAO CORPORATION (JP) | 1994-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210363147-A1 | NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS | DGAT2, DGAT1, ACAT2 | MAPT 844/4885POLB 4250/4885NPC1 82/4885 |
| US-11976061-B2 | Preparation of benzimidazolone derivatives as novel diacylglyceride O-acyltransferase 2 inhibitors | DGAT2, DGAT1, ACAT2 | MAPT 1202/4885POLB 4417/4885NPC1 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.